Susan T. Shero

Circulation · 2012–2015

A researcher in the Science corpus: 8 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Whom Susan T. Shero trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Lynne Stokes

Papers from Susan T. Shero's perspective

Ordered by how strongly the researchers Susan T. Shero trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Introduction to Variance Estimation
  2. Cardiovascular Benefits and Diabetes Risks of Statin Therapy in Primary Prevention (The Lancet)
  3. Statistical Principles in Experimental Design
  4. Prevalence and trends in obesity among US adults, 1999-2000. (Journal of the American Medical Association (JAMA))
  5. Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
  6. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. (Journal of the American Medical Association (JAMA))
  7. 2013 ACC/AHA guideline on the assessment of cardiovascular risk. (Journal of the American College of Cardiology)
  8. High-dose atorvastatin after stroke or transient ischemic attack.
  9. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. (New England Journal of Medicine)
  10. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. (New England Journal of Medicine)

Their papers